Sign in
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
Journal article   Open access  Peer reviewed

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Shalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, Jenny Chang-Claude, Francesmary Modugno, Thilo Dörk, Peter Hillemanns, Leah Preus, Keith L Knutson, Paul K Wallace, …
Oncotarget, Vol.7(43), pp.69097-69110
10/25/2016
PMCID: PMC5340115
PMID: 27533245

Abstract

Adenocarcinoma, Clear Cell - genetics Adenocarcinoma, Clear Cell - immunology Adult Aged Carcinoma, Ovarian Epithelial Female Gene Expression Regulation, Neoplastic Gene Frequency Genetic Predisposition to Disease - genetics Genotype Humans Middle Aged Neoplasms, Glandular and Epithelial - genetics Neoplasms, Glandular and Epithelial - immunology Ovarian Neoplasms - genetics Ovarian Neoplasms - immunology Polymorphism, Single Nucleotide Protein-Serine-Threonine Kinases - genetics Receptor, Transforming Growth Factor-beta Type II Receptors, Transforming Growth Factor beta - genetics Risk Factors T-Lymphocytes, Regulatory - immunology T-Lymphocytes, Regulatory - metabolism
url
https://doi.org/10.18632/oncotarget.10215View
Version of Record (VoR) Open

Metrics

47 readers on Mendeley
1 readers on CiteULike

Details